BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7762743)

  • 1. [Diagnosis of heterozygote carrier of mutant gene of 21-hydroxylase].
    Dzenis IG; Iudina TN; Brykova EK; Bakharev VA; Fanchenko ND
    Akush Ginekol (Mosk); 1995; (1):21-3. PubMed ID: 7762743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of heterozygotic carriers of 21-hydroxylase deficiency: sensitivity of ACTH stimulation tests.
    Witchel SF; Lee PA
    Am J Med Genet; 1998 Apr; 76(4):337-42. PubMed ID: 9545098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a heterozygote advantage in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Witchel SF; Lee PA; Suda-Hartman M; Trucco M; Hoffman EP
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2097-101. PubMed ID: 9215278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency.
    Costa-Barbosa FA; Tonetto-Fernandes VF; Carvalho VM; Nakamura OH; Moura V; Bachega TA; Vieira JG; Kater CE
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):700-6. PubMed ID: 20846292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-MS/MS based determination of basal- and ACTH-stimulated plasma concentrations of 11 steroid hormones: implications for detecting heterozygote CYP21A2 mutation carriers.
    Kulle AE; Riepe FG; Hedderich J; Sippell WG; Schmitz J; Niermeyer L; Holterhus PM
    Eur J Endocrinol; 2015 Oct; 173(4):517-24. PubMed ID: 26315375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Congenital dysfunction of adrenal cortex - detection of new mutant gene of 21-hydroxylase].
    Dzenis IG; Evgrafov OV; Brykova EK; Iudina TN; Bakharev VA; Fanchenko ND
    Vestn Ross Akad Med Nauk; 1994; (12):29-33. PubMed ID: 7742654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [21 hydroxylase deficiency: new strategies emerging from molecular studies].
    Morel Y; Tardy V; Costa JM; Forest MG; David M
    Ann Endocrinol (Paris); 2003 Dec; 64(6):456-70. PubMed ID: 15067252
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucocorticoid withdrawal - heterozygous carriers of congenital adrenal hyperplasia at risk?
    Brackmann F; Dörr HG; Bartram CR; Hinderhofer K; Holter W; Langer T
    Klin Padiatr; 2012 Oct; 224(6):392-3. PubMed ID: 22915453
    [No Abstract]   [Full Text] [Related]  

  • 9. Who is a carrier? Detection of unsuspected mutations in 21-hydroxylase deficiency.
    Witchel SS; Lee PA; Trucco M
    Am J Med Genet; 1996 Jan; 61(1):2-9. PubMed ID: 8741909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular biology of the adrenogenital syndrome. New possibilities of heterozygote screening].
    Böhm BO; Rosak C; Böhm TL; White PC; Schöffling K
    Dtsch Med Wochenschr; 1987 Jan; 112(3):87-9. PubMed ID: 3492354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adrenogenital syndrome with 21-hydroxylase deficiency].
    Dörr HG; Sippell WG
    Monatsschr Kinderheilkd; 1993 Jul; 141(7):609-21. PubMed ID: 8413342
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormonal studies in obligate heterozygotes and siblings of patients with 11 beta-hydroxylase deficiency congenital adrenal hyperplasia.
    Pang S; Levine LS; Lorenzen F; Chow D; Pollack M; Dupont B; Genel M; New MI
    J Clin Endocrinol Metab; 1980 Mar; 50(3):586-9. PubMed ID: 6244328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency.
    Speiser PW; New MI
    J Clin Endocrinol Metab; 1987 Jan; 64(1):86-91. PubMed ID: 3023431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of patient and carrier genes with congenital steroid 21-hydroxylase deficiency by using polymerase chain reaction and single strand conformation polymorphism.
    Tajima T; Fujieda K; Nakayama K; Fujii-Kuriyama Y
    J Clin Invest; 1993 Nov; 92(5):2182-90. PubMed ID: 8227333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [21-Hydroxylase deficiency. Clinical expression of heterozygote carriers in a family].
    Colle M; Battin J
    Arch Fr Pediatr; 1984; 41(7):483-5. PubMed ID: 6333857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Features of adrenal cortex function in heterozygous carriers of 21-hydroxylase deficiency].
    Dzenis IG; Brykova EK; Gertts G; Korsakov SG
    Probl Endokrinol (Mosk); 1991; 37(1):34-7. PubMed ID: 1851301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening 21-hydroxylase deficiency carriers in androgen excess women of Chinese Han nationality].
    Tao H; Lu Z; Zhang B; Wang Y; Sun M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):195-7. PubMed ID: 15793784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene duplications in 21-hydroxylase deficiency: the importance of accurate molecular diagnosis in carrier detection and prenatal diagnosis.
    Ezquieta B; Beneyto M; Muñoz-Pacheco R; Barrio R; Oyarzabal M; Lechuga JL; Luzuriaga C; Hermoso F; Quinteiro S; Martinez S
    Prenat Diagn; 2006 Dec; 26(12):1172-8. PubMed ID: 17042033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for partial 21-hydroxylase deficiency among heterozygote carriers of congenital adrenal hyperplasia.
    Lee PA; Gareis JF
    J Clin Endocrinol Metab; 1975 Aug; 41(2):415-8. PubMed ID: 169282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 21-Hydroxylase deficiency: HLA genotypes and hormonal phenotypes in the families of 32 Italian patients.
    Livieri C; Belvedere M; Martinetti M; Beluffi G; Fiori P; Cogliati CR; Goffredo V; Lorini R; Severi F
    Prog Clin Biol Res; 1985; 200():243-55. PubMed ID: 3001775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.